Aripiprazole for relapse prevention in bipolar disorder: a 26-week placebo-controlled study

被引：0
|
作者：
Sanchez, R
McQuade, R
Marcus, R
Carson, W
Rollin, L
Iwamoto, T
Stock, E
机构：
[1] Bristol Myers Squibb, Pharmaceut Res Inst, Wallingford, CT 06492 USA
[2] Otsuka Amer Pharmaceut Inc, Princeton, NJ USA
[3] Bristol Myers Squibb, Wallingford, CT 06492 USA
[4] Otsuka Pharmaceut Co Ltd, Tokyo, Japan
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S511 / S512
页数：2
相关论文
共 50 条
  • [41] Relapse prevention by acamprosate - Results from a placebo-controlled study on alcohol dependence
    Sass, H
    Soyka, M
    Mann, K
    Zieglgansberger, W
    Hippius, H
    Dieterle, D
    Dilling, H
    Wetterling, T
    John, U
    Kanitz, RD
    Veltrup, C
    Buscher, M
    Richartz, E
    Overberg, B
    Segerath, KD
    Haseke, J
    Landefeld, H
    Gross, J
    Krauss, N
    Niedermeyer, U
    vonKeyserlingk, HG
    Kretschmar, C
    Gienke, E
    Haas, S
    Bialonski, HG
    Toelle, R
    Poehlke, T
    Oskent, A
    Ziegler, B
    Trabert, W
    Weise, R
    Kroh, T
    Kielstein, V
    Boning, J
    ARCHIVES OF GENERAL PSYCHIATRY, 1996, 53 (08) : 673 - 680
  • [42] Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study
    Calabrese, Joseph R.
    Sanchez, Raymond
    Jin, Na
    Amatniek, Joan
    Cox, Kevin
    Johnson, Brian
    Perry, Pamela
    Hertel, Peter
    Such, Pedro
    Salzman, Phyllis M.
    McQuade, Robert D.
    Nyilas, Margaretta
    Carson, William H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (03) : 324 - +
  • [43] A Double-Blind and Placebo-Controlled Trial of Aripiprazole in Symptomatic Youths at Genetic High Risk for Bipolar Disorder
    Findling, Robert L.
    Youngstrom, Eric A.
    Rowles, Brieana M.
    Deyling, Elizabeth
    Lingler, Jacqui
    Stansbrey, Robert J.
    McVoy, Molly
    Lytle, Sarah
    Calabrese, Joseph R.
    McNamara, Nora K.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (10) : 864 - 874
  • [44] Oral testosterone supplementation and chronic low-grade inflammation in elderly men: A 26-week randomized, placebo-controlled trial
    Nakhai-Pour, Haraid Reza
    Grobbee, Diederick E.
    Emmelot-Vonk, Marlelle H.
    Bats, Michiel L.
    Verhaar, Harald J. J.
    van der Schouw, Yvonne T.
    AMERICAN HEART JOURNAL, 2007, 154 (06) : 1228.e1 - 1228.e7
  • [45] 26-week effects of placebo-controlled pramipexole on overall severity, night/day symptoms, and augmentation risk in Restless Legs syndrome
    Trenkwalder, C.
    Hoegl, B.
    Garcia-Borreguero, D.
    Ferini-Strambi, L.
    Poewe, W.
    Brenner, S.
    Sohr, M.
    MOVEMENT DISORDERS, 2009, 24 : S447 - S448
  • [46] Aripiprazole for relapse prevention in bipolar disorder: results from the open-label stabilization study phase
    Carson, WH
    Sanchez, R
    Rollin, L
    Carlson, BV
    Pikalov, A
    BIPOLAR DISORDERS, 2005, 7 : 41 - 41
  • [47] Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial
    Phillips, Katharine A.
    Keshaviah, Aparna
    Dougherty, Darin D.
    Stout, Robert L.
    Menard, William
    Wilhelm, Sabine
    AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (09): : 887 - 895
  • [48] Adjunctive tianeptine treatment for bipolar disorder: A 24-week randomized, placebo-controlled, maintenance trial
    Kauer-Sant'Anna, Marcia
    Frey, Benicio N.
    Fijtman, Adam
    Loredo-Souza, Ana C.
    Dargel, Aroldo A.
    Pfaffenseller, Bianca
    Wollenhaupt-Aguiar, Bianca
    Gazalle, Fernando K.
    Colpo, Gabriela D.
    Passos, Ives C.
    Bucker, Joana
    Walz, Julio C.
    Jansen, Karen
    Mendes Cereser, Keila M.
    Burke Bridi, Kelen P.
    Soria, Lisiane dos Santos
    Kunz, Mauricio
    Pinho, Michele
    Kapczinski, Natalia S.
    Goi, Pedro D.
    Magalhaes, Pedro V. S.
    Reckziegel, Ramiro
    Burque, Renan K.
    Cardoso, Taiane de Azevedo
    Kapczinski, Flavio
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (04) : 502 - 510
  • [49] A 24-week randomized, placebo-controlled trial of adjunctive tianeptine in the maintenance treatment of bipolar disorder
    Kapczinski, F.
    Kapczinski, N.
    Passos, I.
    Jansen, K.
    Magalhaes, P.
    Kunz, M.
    Goi, P.
    Frey, B.
    Kauer-Sant'Anna, M.
    BIPOLAR DISORDERS, 2017, 19 : 119 - 119
  • [50] PLACEBO-CONTROLLED TRIAL OF FLUOXETINE AS AN ADJUNCT TO RELAPSE PREVENTION IN ALCOHOLICS
    KRANZLER, HR
    BURLESON, JA
    KORNER, P
    DELBOCA, FK
    BOHN, MJ
    BROWN, J
    LIEBOWITZ, N
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (03): : 391 - 397
12345